Details for New Drug Application (NDA): 091273
NDA 091273 describes PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma Ltd, Chartwell Rx, Macleods Pharms, Pharmobedient, Teva Pharms Usa, and Torrent Pharms Ltd, and is included in six NDAs. It is available from five suppliers. Additional details are available on the PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE profile page.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
Summary for 091273
| Tradename: | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE |
| Applicant: | Chartwell Rx |
| Ingredient: | metformin hydrochloride; pioglitazone hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG;EQ 15MG BASE | ||||
| Approval Date: | Apr 16, 2013 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 850MG;EQ 15MG BASE | ||||
| Approval Date: | Apr 16, 2013 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
